Rare but severe liver side-effects reported among South African patients starting efavirenz-based ART
HIV/HBV co-infection linked to worse immune recovery and death, but tenofovir improves outcomes
In Option B+, side-effects and needing time to think are key reasons for not taking HIV medication
Denmark shows first clear evidence of the success of treatment as prevention in gay men in a high income country
HIV rapidly develops resistance to gene-editing cure technology
Multiple social and health factors associated with irregular attendance at London HIV clinics
People not taking HIV treatment feel under pressure to ‘do the right thing’
Resistance to anti-HIV drugs in steep decline in Switzerland
VRC01 antibody delays but does not prevent HIV rebound after antiretroviral treatment interruption
